Next Article in Journal
FRI-1 Is an Anti-Cancer Isoquinolinequinone That Inhibits the Mitochondrial Bioenergetics and Blocks Metabolic Shifts by Redox Disruption in Breast Cancer Cells
Next Article in Special Issue
Oxidative Stress and X-ray Exposure Levels-Dependent Survival and Metabolic Changes in Murine HSPCs
Previous Article in Journal
Redox-Modulating Capacity and Antineoplastic Activity of Wastewater Obtained from the Distillation of the Essential Oils of Four Bulgarian Oil-Bearing Roses
Previous Article in Special Issue
Exploring the Leukemogenic Potential of GATA-1S, the Shorter Isoform of GATA-1: Novel Insights into Mechanisms Hampering Respiratory Chain Complex II Activity and Limiting Oxidative Phosphorylation Efficiency
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses

1
Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia
2
Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia
3
John Hunter Children’s Hospital, New Lambton Heights, NSW 2308, Australia
4
Calvary Mater Hospital, Waratah, NSW 2298, Australia
5
Reproductive Science Group, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW 2308, Australia
*
Author to whom correspondence should be addressed.
Antioxidants 2021, 10(10), 1616; https://doi.org/10.3390/antiox10101616
Submission received: 8 September 2021 / Revised: 7 October 2021 / Accepted: 9 October 2021 / Published: 14 October 2021
(This article belongs to the Special Issue Reactive Oxygen Species (ROS), Haematopoiesis and Leukaemia)

Abstract

Acute lymphoblastic leukaemia (ALL) is the most common cancer diagnosed in children and adolescents. Approximately 70% of patients survive >5-years following diagnosis, however, for those that fail upfront therapies, survival is poor. Reactive oxygen species (ROS) are elevated in a range of cancers and are emerging as significant contributors to the leukaemogenesis of ALL. ROS modulate the function of signalling proteins through oxidation of cysteine residues, as well as promote genomic instability by damaging DNA, to promote chemotherapy resistance. Current therapeutic approaches exploit the pro-oxidant intracellular environment of malignant B and T lymphoblasts to cause irreversible DNA damage and cell death, however these strategies impact normal haematopoiesis and lead to long lasting side-effects. Therapies suppressing ROS production, especially those targeting ROS producing enzymes such as the NADPH oxidases (NOXs), are emerging alternatives to treat cancers and may be exploited to improve the ALL treatment. Here, we discuss the roles that ROS play in normal haematopoiesis and in ALL. We explore the molecular mechanisms underpinning overproduction of ROS in ALL, and their roles in disease progression and drug resistance. Finally, we examine strategies to target ROS production, with a specific focus on the NOX enzymes, to improve the treatment of ALL.
Keywords: acute lymphoblastic leukaemia; reactive oxygen species; oxidative stress; NADPH oxidases; antioxidants; redox homeostasis; second messenger signalling; oxidative DNA damage; resistance; oncogenic signalling; cysteine oxidation; kinase; phosphatase acute lymphoblastic leukaemia; reactive oxygen species; oxidative stress; NADPH oxidases; antioxidants; redox homeostasis; second messenger signalling; oxidative DNA damage; resistance; oncogenic signalling; cysteine oxidation; kinase; phosphatase

Share and Cite

MDPI and ACS Style

Mannan, A.; Germon, Z.P.; Chamberlain, J.; Sillar, J.R.; Nixon, B.; Dun, M.D. Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses. Antioxidants 2021, 10, 1616. https://doi.org/10.3390/antiox10101616

AMA Style

Mannan A, Germon ZP, Chamberlain J, Sillar JR, Nixon B, Dun MD. Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses. Antioxidants. 2021; 10(10):1616. https://doi.org/10.3390/antiox10101616

Chicago/Turabian Style

Mannan, Abdul, Zacary P. Germon, Janis Chamberlain, Jonathan R. Sillar, Brett Nixon, and Matthew D. Dun. 2021. "Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses" Antioxidants 10, no. 10: 1616. https://doi.org/10.3390/antiox10101616

APA Style

Mannan, A., Germon, Z. P., Chamberlain, J., Sillar, J. R., Nixon, B., & Dun, M. D. (2021). Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses. Antioxidants, 10(10), 1616. https://doi.org/10.3390/antiox10101616

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop